Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

The New England Journal of Medicine
A M Di BisceglieJ H Hoofnagle

Abstract

Infection with the hepatitis C virus may result in chronic liver disease for which no effective therapy is now available. We studied the effects of recombinant human interferon alfa in a prospective, randomized, double-blind, placebo-controlled trial in patients with well-documented chronic hepatitis C. Forty-one patients were enrolled in the trial, 37 of whom were later found to have antibody to hepatitis C virus. Twenty-one patients received interferon alfa (2 million units) subcutaneously three times weekly for six months, and 20 received placebo. The mean serum aminotransferase levels and the histologic features of the liver improved significantly in the patients treated with interferon but not in the patients given placebo. Ten patients treated with interferon (48 percent) had a complete response, defined as a decline in mean serum aminotransferase levels to the normal range during therapy; three others had a decrease in mean aminotransferase levels of more than 50 percent. After treatment ended, however, serum aminotransferases usually returned to pretreatment levels; 6 to 12 months after the discontinuation of interferon therapy, only two patients (10 percent) still had normal values. We conclude that interferon alfa the...Continue Reading

References

Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
May 1, 1985·Gastroenterology·R L KoretzG L Gitnick
Jun 1, 1982·The Journal of Infectious Diseases·M J AlterG M Matanoski
Nov 1, 1981·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·J K Boitnott, W C Maddrey
Sep 1, 1981·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·R G KnodellJ Wollman

❮ Previous
Next ❯

Citations

Aug 10, 1999·American Journal of Hematology·S M LichtmanA Buchbinder
Apr 1, 1997·Journal of Medical Virology·M J AmaroV Carreño
Mar 14, 2000·Journal of Magnetic Resonance Imaging : JMRI·K ItoT Gabata
Sep 1, 1993·American Journal of Hematology·L M Aledort
Aug 1, 1994·American Journal of Hematology·Y FujiiN Matumoto
Apr 16, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·K E ShermanZ D Goodman
Apr 16, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W C ChowP Marcellin
May 15, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M EnomotoT Monna
May 15, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A KasaharaK Okita
Oct 2, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·D T LauJ H Hoofnagle
Jan 27, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T V InglesbyD L Thomas
Sep 25, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T MurakamiC Sato
Jan 1, 1994·Journal of Clinical Laboratory Analysis·R A McPherson
Mar 1, 1993·Journal of Magnetic Resonance Imaging : JMRI·D G MitchellR Rubin
Aug 1, 1991·Journal of Medical Virology·J A GarsonF B Bianchi
Jul 1, 1992·Journal of Medical Virology·V CarreñoI Castillo
May 1, 1993·Journal of Medical Virology·T J LiangH E Blum

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.